• Publications
  • Influence
TRANSMISSION OF HEPATITIS B FROM HEPATITIS-B-SERONEGATIVE SUBJECTS
TLDR
PCR with HBV primers may unambigously identify HBV infectious particles among non-A, non-B viruses and is a potentially useful diagnostic test for detection of HBV DNA sequences in serum.
Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: significance and therapeutic implications.
TLDR
A need for liver biopsy and antiviral treatment before kidney transplantation is suggested and the isolation of anti-HCV positive subjects in the dialysis setting should be evaluated to reduce patient-to-patient transmission of HCV.
Hepatitis C viremia and anti-HCV antibodies in alcoholics.
TLDR
Results indicate thatHCV replication is maintained in most alcoholics who score positive for anti-HCV Ab in the RIBA2 test, and that HCV viremia can be associated with histological features typical of alcoholic liver disease.
Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
TLDR
Reduction of serum HBV DNA in some of persons with chronic active HBV replication suggests that induction of CD4+ T cell responses could be important in controlling viremia during vaccine therapy of chronic HBV carriers.
Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease.
TLDR
The prevalence of anti-HCV antibodies in HCC (58.2%) was significantly higher than in the other groups (AC, 35.9%; NCA, 17.7%).
Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg‐Negative Patients: A Study of a Low‐endemic Area
TLDR
Sequence analysis of a hypervariable region in the E2/NS1 gene of HCV showed significant variations between the viral molecules isolated from the nontumorous, tumorous and serum samples and assessed that liver tumor cells did contain HCV RNA genomes.
Efficacy and limitations of a specific immunotherapy in chronic hepatitis B.
TLDR
This controlled study offers direct evidence that the HBV vaccine may decrease HBV replication in chronic hepatitis B patients and emphasizes the need for reinforced immunization strategies as well as combination therapies.
Immunotherapy of chronic hepatitis B by anti HBV vaccine.
TLDR
In responders to vaccine, an induction of specific proliferative responses was observed and this may contribute to the potential efficacy of anti-HBV vaccine therapy.
Azathioprine hepatitis in kidney transplant recipients. A predisposing role of chronic viral hepatitis.
TLDR
In kidney transplant recipients, azathioprine hepatitis seems to be facilitated or induced by hepatitis B virus or hepatitis C virus chronic hepatitis, which should be combined with the diagnostic evaluation and the treatment of viral liver diseases.
...
1
2
3
4
5
...